Stocks
Mutual Funds
ETFs
Pro Tools
Terminal
WealthView
Pricing
Learn More
stocks
CORONA
CORONA

CORONA Remedies Ltd.

NSE: CORONA
BSE: 544644
Sector: Healthcare
Industry: Pharmaceuticals
2,027.00+47.6 (+2.40%)
9 Jul, 3:29 PM

Stock Scores

Quality Score

89.2 / 100

Value Score

13.8 / 100

Price Momentum Score

68.8 / 100

QVM Score

61.6 / 100

Key Metrics

Market Cap
12106.00
P/E (TTM)
65.40
P/B
16.21
P/S (TTM)
8.63
EV/EBITDA
41.67
CAPE (5Y)
-
ROE (TTM)
27.36
ROCE (TTM)
31.86
ROA (TTM)
17.34
Avg 3Y ROE
25.07
Earnings 3Y CAGR
29.66
Sales 3Y CAGR
16.65
Sales 5Y CAGR
-
Debt/Equity
0.22
Consensus TP
1948.50
Strong Buy %
-
Promoter Holding
69.00
Pledged %
0.00

Share Price

Track CORONA Remedies Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.

1 Week returns: 0.90 %
Low
1,960.1
High
2,082.1
1 Month returns: 14.26 %
Low
1,656.6
High
2,100.7
1 Year returns: –
3 Year CAGR: –
5 Year CAGR: –
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.

Financial Snapshot

See detailed analysis

Multi-year trends for CORONA Remedies Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

CORONA Remedies Ltd. Shareholding Pattern

Quarterly breakdown of CORONA Remedies Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in CORONA Remedies Ltd. shares as reported to NSE and BSE.

Frequently Asked Questions

What is the current share price of CORONA Remedies Ltd.?
The current share price of CORONA Remedies Ltd. is ₹ 2,027.00 as of 9 Jul 2026.
What is the market capitalisation of CORONA Remedies Ltd.?
The market capitalisation of CORONA Remedies Ltd. stands at ₹ 12,106.00 Cr.
What is the PE ratio of CORONA Remedies Ltd.?
The Price-to-Earnings (PE) ratio of CORONA Remedies Ltd. is 65.40 as of the latest trailing twelve months data.
What is the ROE and ROCE of CORONA Remedies Ltd.?
CORONA Remedies Ltd. has a Return on Equity (ROE) of 27.36% and a Return on Capital Employed (ROCE) of 31.86% as per the latest financial reports.
What is the 52-week high and low of CORONA Remedies Ltd.?
The 52-week high of CORONA Remedies Ltd. is - and the 52-week low is -.
What is the dividend yield of CORONA Remedies Ltd.?
The dividend yield of CORONA Remedies Ltd. is 0.00% based on the current market price.
What is the FII and DII holding in CORONA Remedies Ltd.?
Foreign Institutional Investors (FII) hold 2.25%, Domestic Institutional Investors (DII) hold 6.93% and retail/public investors hold 20.97% of CORONA Remedies Ltd. shares.
What sector does CORONA Remedies Ltd. belong to?
CORONA Remedies Ltd. operates in the Healthcare sector.
What is the beta of CORONA Remedies Ltd.?
The beta of CORONA Remedies Ltd. is -, indicating its price volatility relative to the broader market.
What is the RSI of CORONA Remedies Ltd.?
The 14-day Relative Strength Index (RSI) of CORONA Remedies Ltd. is 63.44, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.